Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

被引：0
|
作者：
Mario Giuliano
Antonio Giordano
Summer Jackson
Kenneth R Hess
Ugo De Giorgi
Michal Mego
Beverly C Handy
Naoto T Ueno
Ricardo H Alvarez
Michelino De Laurentiis
Sabino De Placido
Vicente Valero
Gabriel N Hortobagyi
James M Reuben
Massimo Cristofanilli
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Hematopathology
[2] University of Naples Federico II,Department of Molecular and Clinical Oncology and Endocrinology
[3] Breast Center,Department of Biostatistics
[4] Baylor College of Medicine,Department of Medical Oncology, School of Medicine
[5] Breast Medical Oncology,undefined
[6] The University of Texas MD Anderson Cancer Center,undefined
[7] The University of Texas MD Anderson Cancer Center,undefined
[8] Medical Oncology,undefined
[9] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,undefined
[10] Comenius University,undefined
[11] Laboratory Medicine,undefined
[12] The University of Texas MD Anderson Cancer Center,undefined
[13] Department of Medical Oncology,undefined
[14] Fox Chase Medical Center,undefined
来源：
Breast Cancer Research | / 13卷
关键词：
Overall Survival; Bevacizumab; Trastuzumab; Lapatinib; Circulate Tumor Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
    Giuliano, Mario
    Giordano, Antonio
    Jackson, Summer
    Hess, Kenneth R.
    De Giorgi, Ugo
    Mego, Michal
    Handy, Beverly C.
    Ueno, Naoto T.
    Alvarez, Ricardo H.
    De Laurentiis, Michelino
    De Placido, Sabino
    Valero, Vicente
    Hortobagyi, Gabriel N.
    Reuben, James M.
    Cristofanilli, Massimo
    BREAST CANCER RESEARCH, 2011, 13 (03)
  • [2] Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line therapy
    Giuliano, M.
    Giordano, A.
    Hsu, L.
    Handy, B. C.
    Ueno, N. T.
    Andreopoulou, E.
    Alvarez, R. H.
    Valero, V.
    Hortobagyi, G. N.
    Cristofanilli, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy
    Magbanua, Mark Jesus M.
    Hendrix, Laura H.
    Hyslop, Terry
    Barry, William T.
    Winer, Eric P.
    Hudis, Clifford
    Toppmeyer, Deborah
    Carey, Lisa Anne
    Partridge, Ann H.
    Pierga, Jean-Yves
    Fehm, Tanja
    Vidal-Martinez, Jose
    Mavroudis, Dimitrios
    Garcia-Saenz, Jose A.
    Stebbing, Justin
    Gazzaniga, Paola
    Manso, Luis
    Zamarchi, Rita
    Luisa Antelo, Maria
    De Mattos-Arruda, Leticia
    Generali, Daniele
    Caldas, Carlos
    Munzone, Elisabetta
    Dirix, Luc
    Delson, Amy L.
    Burstein, Harold J.
    Qadir, Misbah
    Ma, Cynthia
    Scott, Janet H.
    Bidard, Francois-Clement
    Park, John W.
    Rugo, Hope S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (04): : 443 - 452
  • [4] High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
    Pierga, J. -Y.
    Hajage, D.
    Bachelot, T.
    Delaloge, S.
    Brain, E.
    Campone, M.
    Dieras, V.
    Rolland, E.
    Mignot, L.
    Mathiot, C.
    Bidard, F. -C.
    ANNALS OF ONCOLOGY, 2012, 23 (03) : 618 - 624
  • [5] Detection of circulating tumor cells (CTCs) is a prognostic factor in first-line metastatic breast cancer (MBC)
    Cristofanilli, M
    Reuben, JM
    Fritsche, HA
    Hayes, DF
    Budd, TG
    Ellis, MJ
    Stopeck, A
    Miller, CM
    Matera, J
    Allard, JW
    Terstappen, LWMM
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S225 - S225
  • [6] Prospective multi centric trial evaluating prognostic and predictive value of circulating tumor cells in first-line chemotherapy metastatic breast patients
    Pierga, J.
    Bachelot, T. D.
    Bidard, F.
    Delaloge, S.
    Brain, E.
    Campone, M.
    Asselain, B.
    Mathiot, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Clinical significance of tumor markers as prognostic factors in patients with metastatic gastric cancer receiving first-line chemotherapy.
    Jo, J.
    Ryu, M.
    Koo, D.
    Ryoo, B.
    Kim, H. J.
    Lee, J.
    Chang, H.
    Kim, T. W.
    Choi, K. D.
    Lee, H.
    Jung, H.
    Kim, K. C.
    Yook, J. H.
    Oh, S. T.
    Kim, B. S.
    Kim, J.
    Kang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Taxanes as a First-Line Systemic Treatment in Metastatic Breast Cancer
    Urquhart, Laura M.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2013, 17 (01) : 15 - 21
  • [9] The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab
    Simkens, L. H. J.
    Tol, J.
    Terstappen, L. W. M. M.
    Teerenstra, S.
    Punt, C. J. A.
    Nagtegaal, I. D.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2447 - 2448
  • [10] Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment
    Muinelo-Romay, Laura
    Vieito, Maria
    Abalo, Alicia
    Alonso Nocelo, Marta
    Baron, Francisco
    Anido, Urbano
    Brozos, Elena
    Vazquez, Francisca
    Aguin, Santiago
    Abal, Miguel
    Lopez Lopez, Rafael
    CANCERS, 2014, 6 (01): : 153 - 165
12345